tirzepatide for ckd Prescribing Practices and Efficacy in Patients with Diabet | DMSO Join a trial on tirzepatide

This ensures that the medication remains at steady levels in your body, enhancing its effectiveness and minimizing the chance of missing a dose

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF

Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound)

If your next scheduled dose is more than four days away, take the missed dose as soon as you remember and continue your regular weekly schedule

the dosage strength that marries effectiveness and tolerability) is the same

This medication helps people achieve and maintain a healthier body weight